---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018806"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-10-21T23:59:59+00:00"
generated_at: "2026-05-17T03:03:03.834562+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions stockholders approve reverse stock split, warrant share issuance, and incentive plan expansion

## Summary
- Elected four directors: Boyages, Hurd, Isenberg, Fraser. Boyages received 1,349,921 for, 503,182 withheld.
- Approved amendment to 2019 Long Term Incentive Plan, increasing authorized shares from 1.3M to 1.795M (495,000 new shares).
- Approved issuance of up to 4,147,616 shares upon warrant exercise (over 20% of outstanding common stock).
- Approved reverse stock split at ratio of 1-for-2 to 1-for-10 within 12 months, at Board's discretion, to regain Nasdaq bid price compliance.
- Ratified UHY LLP as independent auditor for fiscal year ending June 30, 2026 (4,246,183 for, 227,964 against).

## SEC filing metadata
- accession: 0001493152-25-018806
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-10-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315225018806/0001493152-25-018806-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315225018806/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018806
- JSON: https://secwatch.observer/filing/0001493152-25-018806.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018806.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.